Skip to main content
Top
Published in: Acta Neurochirurgica 12/2023

14-11-2023 | Original Article

Revision and removal of vagus nerve stimulation systems: twenty-five years’ experience

Authors: Lydia Kaoutzani, Liam V. Goldman, Keaton Piper, Manish Kumar, Fernando L. Vale

Published in: Acta Neurochirurgica | Issue 12/2023

Login to get access

Abstract

Background

Epilepsy, a disease characterized by recurrent seizures, is a common chronic neurologic condition. Antiepileptic drugs (AED) are the mainstay of treatment for epilepsy. Vagus nerve stimulation (VNS) surgery is an adjuvant therapy for the treatment of drug refractory epilepsy (DRE). VNS revision and implant removal surgeries remain common.

Methods

Using a single neurosurgeon data registry for epilepsy surgery, we retrospectively analyzed a total of 824 VNS surgeries. Patients were referred to two Level IV Comprehensive Epilepsy centers (from 08/1997 to 08/2022) for evaluation. Patients were divided into four groups: new device placement, revision surgery, removal surgery, and battery replacement for end-of-life of the generator. The primary endpoint was to analyze the reasons that led patients to undergo revision and removal surgeries. The time period from the index surgery to the removal surgery was also calculated.

Results

The median age of patients undergoing any type of surgery was 34 years. The primary reason for revision surgeries was device malfunction, followed by patients’ cosmetic dissatisfaction. There was no statistical sex-difference in revision surgeries. The median age and body mass index (BMI) of patients who underwent revision surgery were 38 years and 26, respectively. On the other hand, the primary reason for removal was lack of efficacy, followed again by cosmetic dissatisfaction. The survival analysis showed that 43% of VNS device remained in place for 5 years and 50% of the VNS devices were kept for 1533 days or 4.2 years.

Conclusions

VNS therapy is safe and well-tolerated. VNS revision and removal surgeries occur in less than 5% of cases. More importantly, attention to detail and good surgical technique at the time of the index surgery can increase patient satisfaction, minimize the need for further surgeries, and improve acceptance of the VNS technology.
Literature
1.
go back to reference Aalbers MW, Rijkers K, Klinkenberg S, Majoie M, Cornips EM (2015) Vagus nerve stimulation lead removal or replacement: surgical technique, institutional experience, and literature overview. Acta Neurochir (Wien) 157(11):1917–1924CrossRefPubMed Aalbers MW, Rijkers K, Klinkenberg S, Majoie M, Cornips EM (2015) Vagus nerve stimulation lead removal or replacement: surgical technique, institutional experience, and literature overview. Acta Neurochir (Wien) 157(11):1917–1924CrossRefPubMed
2.
go back to reference Afra P, Adamolekun B, Aydemir S, Watson GDR (2021) Evolution of the vagus nerve stimulation (vns) therapy system technology for drug-resistant epilepsy. Front Med Technol 3:696543CrossRefPubMedPubMedCentral Afra P, Adamolekun B, Aydemir S, Watson GDR (2021) Evolution of the vagus nerve stimulation (vns) therapy system technology for drug-resistant epilepsy. Front Med Technol 3:696543CrossRefPubMedPubMedCentral
3.
go back to reference Agarwal G, Wilfong AA, Edmonds JL Jr (2011) Surgical revision of vagus nerve stimulation electrodes in children. Otolaryngol Head Neck Surg 144(1):123–124CrossRefPubMed Agarwal G, Wilfong AA, Edmonds JL Jr (2011) Surgical revision of vagus nerve stimulation electrodes in children. Otolaryngol Head Neck Surg 144(1):123–124CrossRefPubMed
4.
go back to reference Air EL, Ghomri YM, Tyagi R, Grande AW, Crone K, Mangano FT (2009) Management of vagal nerve stimulator infections: do they need to be removed? J Neurosurg Pediatr 3(1):73–78CrossRefPubMed Air EL, Ghomri YM, Tyagi R, Grande AW, Crone K, Mangano FT (2009) Management of vagal nerve stimulator infections: do they need to be removed? J Neurosurg Pediatr 3(1):73–78CrossRefPubMed
5.
go back to reference Baaj AA, Benbadis SR, Tatum WO, Vale FL (2008) Trends in the use of vagus nerve stimulation for epilepsy: analysis of a nationwide database. Neurosurg Focus 25(3):E10CrossRefPubMed Baaj AA, Benbadis SR, Tatum WO, Vale FL (2008) Trends in the use of vagus nerve stimulation for epilepsy: analysis of a nationwide database. Neurosurg Focus 25(3):E10CrossRefPubMed
6.
go back to reference Benbadis SR, Tatum WO, Vale FL (2000) When drugs don’t work: an algorithmic approach to medically intractable epilepsy. Neurology 55(12):1780–1784CrossRefPubMed Benbadis SR, Tatum WO, Vale FL (2000) When drugs don’t work: an algorithmic approach to medically intractable epilepsy. Neurology 55(12):1780–1784CrossRefPubMed
8.
go back to reference Champeaux C, Landre E, Chassoux F, Mann MW, Devaux B, Turak B (2017) Vagus nerve stimulation removal or replacement involving the lead and the electrode: surgical technique, institutional experience and outcome. World Neurosurg 99:275–281CrossRefPubMed Champeaux C, Landre E, Chassoux F, Mann MW, Devaux B, Turak B (2017) Vagus nerve stimulation removal or replacement involving the lead and the electrode: surgical technique, institutional experience and outcome. World Neurosurg 99:275–281CrossRefPubMed
9.
go back to reference Couch JD, Gilman AM, Doyle WK (2016) Long-term expectations of vagus nerve stimulation: a look at battery replacement and revision surgery. Neurosurgery 78(1):42–46CrossRefPubMed Couch JD, Gilman AM, Doyle WK (2016) Long-term expectations of vagus nerve stimulation: a look at battery replacement and revision surgery. Neurosurgery 78(1):42–46CrossRefPubMed
11.
go back to reference Englot DJ, Rolston JD, Wright CW, Hassnain KH, Chang EF (2016) Rates and predictors of seizure freedom with vagus nerve stimulation for intractable epilepsy. Neurosurgery 79(3):345–353CrossRefPubMed Englot DJ, Rolston JD, Wright CW, Hassnain KH, Chang EF (2016) Rates and predictors of seizure freedom with vagus nerve stimulation for intractable epilepsy. Neurosurgery 79(3):345–353CrossRefPubMed
12.
go back to reference Espinosa J, Aiello MT, Naritoku DK (1999) Revision and removal of stimulating electrodes following long-term therapy with the vagus nerve stimulator. Surg Neurol 51(6):659–664CrossRefPubMed Espinosa J, Aiello MT, Naritoku DK (1999) Revision and removal of stimulating electrodes following long-term therapy with the vagus nerve stimulator. Surg Neurol 51(6):659–664CrossRefPubMed
13.
go back to reference Fisher RS (2017) The new classification of seizures by the international league against epilepsy 2017. Curr Neurol Neurosci Rep 17(6):48CrossRefPubMed Fisher RS (2017) The new classification of seizures by the international league against epilepsy 2017. Curr Neurol Neurosci Rep 17(6):48CrossRefPubMed
15.
go back to reference Gigliotti MJ, Mao G, Dupre DA, Wilberger J (2018) Vagal nerve stimulation: indications for revision in adult refractory epilepsy. World Neurosurg 120:e1047–e1053CrossRefPubMed Gigliotti MJ, Mao G, Dupre DA, Wilberger J (2018) Vagal nerve stimulation: indications for revision in adult refractory epilepsy. World Neurosurg 120:e1047–e1053CrossRefPubMed
16.
go back to reference Giordano F, Zicca A, Barba C, Guerrini R, Genitori L (2017) Vagus nerve stimulation: surgical technique of implantation and revision and related morbidity. Epilepsia 58(Suppl 1):85–90CrossRefPubMed Giordano F, Zicca A, Barba C, Guerrini R, Genitori L (2017) Vagus nerve stimulation: surgical technique of implantation and revision and related morbidity. Epilepsia 58(Suppl 1):85–90CrossRefPubMed
17.
go back to reference Grolemund GWH (2011) Dates and times made easy with lubridate. J Stat Softw 40(3):1–25CrossRef Grolemund GWH (2011) Dates and times made easy with lubridate. J Stat Softw 40(3):1–25CrossRef
18.
go back to reference Guekht A, Brodie M, Secco M, Li S, Volkers N, Wiebe S (2021) The road to a World Health Organization global action plan on epilepsy and other neurological disorders. Epilepsia 62(5):1057–1063CrossRefPubMed Guekht A, Brodie M, Secco M, Li S, Volkers N, Wiebe S (2021) The road to a World Health Organization global action plan on epilepsy and other neurological disorders. Epilepsia 62(5):1057–1063CrossRefPubMed
20.
go back to reference Koutroumanidis M, Binnie CD, Hennessy MJ, Alarcon G, Elwes RD, Toone BK et al (2003) VNS in patients with previous unsuccessful resective epilepsy surgery: antiepileptic and psychotropic effects. Acta Neurol Scand 107(2):117–121CrossRefPubMed Koutroumanidis M, Binnie CD, Hennessy MJ, Alarcon G, Elwes RD, Toone BK et al (2003) VNS in patients with previous unsuccessful resective epilepsy surgery: antiepileptic and psychotropic effects. Acta Neurol Scand 107(2):117–121CrossRefPubMed
22.
go back to reference Liechty PG, Tubbs RS, Blount JP (2006) The use of a sump antibiotic irrigation system to save infected hardware in a patient with a vagal nerve stimulator: technical note. Surg Neurol 65(1):48–9 (discussion 9-50)CrossRefPubMed Liechty PG, Tubbs RS, Blount JP (2006) The use of a sump antibiotic irrigation system to save infected hardware in a patient with a vagal nerve stimulator: technical note. Surg Neurol 65(1):48–9 (discussion 9-50)CrossRefPubMed
24.
go back to reference Ng WH, Donner E, Go C, Abou-Hamden A, Rutka JT (2010) Revision of vagal nerve stimulation (VNS) electrodes: review and report on use of ultra-sharp monopolar tip. Childs Nerv Syst 26(8):1081–1084CrossRefPubMed Ng WH, Donner E, Go C, Abou-Hamden A, Rutka JT (2010) Revision of vagal nerve stimulation (VNS) electrodes: review and report on use of ultra-sharp monopolar tip. Childs Nerv Syst 26(8):1081–1084CrossRefPubMed
26.
go back to reference O’Reardon JP, Cristancho P, Peshek AD (2006) Vagus nerve stimulation (vns) and treatment of depression: to the brainstem and beyond. Psychiatry (Edgmont) 3(5):54–63PubMed O’Reardon JP, Cristancho P, Peshek AD (2006) Vagus nerve stimulation (vns) and treatment of depression: to the brainstem and beyond. Psychiatry (Edgmont) 3(5):54–63PubMed
27.
go back to reference Orosz I, McCormick D, Zamponi N, Varadkar S, Feucht M, Parain D et al (2014) Vagus nerve stimulation for drug-resistant epilepsy: a European long-term study up to 24 months in 347 children. Epilepsia 55(10):1576–1584CrossRefPubMed Orosz I, McCormick D, Zamponi N, Varadkar S, Feucht M, Parain D et al (2014) Vagus nerve stimulation for drug-resistant epilepsy: a European long-term study up to 24 months in 347 children. Epilepsia 55(10):1576–1584CrossRefPubMed
28.
go back to reference Patel NC, Edwards MS (2004) Vagal nerve stimulator pocket infections. Pediatr Infect Dis J 23(7):681–683CrossRefPubMed Patel NC, Edwards MS (2004) Vagal nerve stimulator pocket infections. Pediatr Infect Dis J 23(7):681–683CrossRefPubMed
29.
go back to reference Perez-Carbonell L, Faulkner H, Higgins S, Koutroumanidis M, Leschziner G (2020) Vagus nerve stimulation for drug-resistant epilepsy. Pract Neurol 20(3):189–198CrossRefPubMed Perez-Carbonell L, Faulkner H, Higgins S, Koutroumanidis M, Leschziner G (2020) Vagus nerve stimulation for drug-resistant epilepsy. Pract Neurol 20(3):189–198CrossRefPubMed
30.
go back to reference Revesz D, Rydenhag B, Ben-Menachem E (2016) Complications and safety of vagus nerve stimulation: 25 years of experience at a single center. J Neurosurg Pediatr 18(1):97–104CrossRefPubMed Revesz D, Rydenhag B, Ben-Menachem E (2016) Complications and safety of vagus nerve stimulation: 25 years of experience at a single center. J Neurosurg Pediatr 18(1):97–104CrossRefPubMed
31.
go back to reference Sjoberg DDWK, Curry M, Lavery JA, Larmarange J (2021) Reproducible summary tables with the gtsummary package. R J 13:570–580CrossRef Sjoberg DDWK, Curry M, Lavery JA, Larmarange J (2021) Reproducible summary tables with the gtsummary package. R J 13:570–580CrossRef
33.
go back to reference Strzelczyk A, Griebel C, Lux W, Rosenow F, Reese JP (2017) The burden of severely drug-refractory epilepsy: a comparative longitudinal evaluation of mortality, morbidity, resource use, and cost using german health insurance data. Front Neurol 8:712CrossRefPubMedPubMedCentral Strzelczyk A, Griebel C, Lux W, Rosenow F, Reese JP (2017) The burden of severely drug-refractory epilepsy: a comparative longitudinal evaluation of mortality, morbidity, resource use, and cost using german health insurance data. Front Neurol 8:712CrossRefPubMedPubMedCentral
34.
go back to reference Spooner A, Chen E, Sowmya A, Sachdev P, Kochan NA, Trollor J et al (2020) A comparison of machine learning methods for survival analysis of high-dimensional clinical data for dementia prediction. Sci Rep 10(1):20410CrossRefPubMedPubMedCentral Spooner A, Chen E, Sowmya A, Sachdev P, Kochan NA, Trollor J et al (2020) A comparison of machine learning methods for survival analysis of high-dimensional clinical data for dementia prediction. Sci Rep 10(1):20410CrossRefPubMedPubMedCentral
35.
go back to reference Spuck S, Tronnier V, Orosz I, Schonweiler R, Sepehrnia A, Nowak G et al (2010) Operative and technical complications of vagus nerve stimulator implantation. Neurosurgery 67(2 Suppl Operative):489–94PubMed Spuck S, Tronnier V, Orosz I, Schonweiler R, Sepehrnia A, Nowak G et al (2010) Operative and technical complications of vagus nerve stimulator implantation. Neurosurgery 67(2 Suppl Operative):489–94PubMed
36.
go back to reference Terry M. Therneau PMG (2000) Modeling survival data: extending the cox model. New York Terry M. Therneau PMG (2000) Modeling survival data: extending the cox model. New York
37.
go back to reference Therneau T (2023) A Package for Survival Analysis in R. R package version 35–5 Therneau T (2023) A Package for Survival Analysis in R. R package version 35–5
38.
go back to reference Trezza A, Landi A, Grioni D, Pirillo D, Fiori L, Giussani C et al (2017) Adverse effects and surgical complications in pediatric patients undergoing vagal nerve stimulation for drug-resistant epilepsy. Acta Neurochir Suppl 124:43–47CrossRefPubMed Trezza A, Landi A, Grioni D, Pirillo D, Fiori L, Giussani C et al (2017) Adverse effects and surgical complications in pediatric patients undergoing vagal nerve stimulation for drug-resistant epilepsy. Acta Neurochir Suppl 124:43–47CrossRefPubMed
39.
go back to reference Vale FL, Ahmadian A, Youssef AS, Tatum WO, Benbadis SR (2011) Long-term outcome of vagus nerve stimulation therapy after failed epilepsy surgery. Seizure 20(3):244–248CrossRefPubMed Vale FL, Ahmadian A, Youssef AS, Tatum WO, Benbadis SR (2011) Long-term outcome of vagus nerve stimulation therapy after failed epilepsy surgery. Seizure 20(3):244–248CrossRefPubMed
40.
go back to reference Waseem H, Raffa SJ, Benbadis SR, Vale FL (2014) Lead revision surgery for vagus nerve stimulation in epilepsy: outcomes and efficacy. Epilepsy Behav 31:110–113CrossRefPubMed Waseem H, Raffa SJ, Benbadis SR, Vale FL (2014) Lead revision surgery for vagus nerve stimulation in epilepsy: outcomes and efficacy. Epilepsy Behav 31:110–113CrossRefPubMed
41.
go back to reference Wickham HAM, Bryan J, Chang W, McGowan LD, François R, Grolemund G, Hayes A, Henry L, Hester J, Kuhn M, Pedersen TL, Miller E, Bache SM, Müller K, Ooms J, Robinson D, Seidel DP, Spinu V, Takahashi K, Vaughan D, Wilke C, Woo K, Yutani H (2019) Welcome to the tidyverse. J Open Source Softw 4(43):1686CrossRef Wickham HAM, Bryan J, Chang W, McGowan LD, François R, Grolemund G, Hayes A, Henry L, Hester J, Kuhn M, Pedersen TL, Miller E, Bache SM, Müller K, Ooms J, Robinson D, Seidel DP, Spinu V, Takahashi K, Vaughan D, Wilke C, Woo K, Yutani H (2019) Welcome to the tidyverse. J Open Source Softw 4(43):1686CrossRef
42.
go back to reference Wozniak SE, Thompson EM, Selden NR (2011) Vagal nerve stimulator infection: a lead-salvage protocol. J Neurosurg Pediatr 7(6):671–675CrossRefPubMed Wozniak SE, Thompson EM, Selden NR (2011) Vagal nerve stimulator infection: a lead-salvage protocol. J Neurosurg Pediatr 7(6):671–675CrossRefPubMed
Metadata
Title
Revision and removal of vagus nerve stimulation systems: twenty-five years’ experience
Authors
Lydia Kaoutzani
Liam V. Goldman
Keaton Piper
Manish Kumar
Fernando L. Vale
Publication date
14-11-2023
Publisher
Springer Vienna
Published in
Acta Neurochirurgica / Issue 12/2023
Print ISSN: 0001-6268
Electronic ISSN: 0942-0940
DOI
https://doi.org/10.1007/s00701-023-05875-1

Other articles of this Issue 12/2023

Acta Neurochirurgica 12/2023 Go to the issue